Short‐Course Selinexor and Decitabine With Homoharringtonine‐Based Chemotherapy for Pretransplant Cytoreduction in TP53‐Altered Complex‐Karyotype Myeloid Neoplasms

The authors declare no conflicts of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.